ID   CHLA-95
AC   CVCL_6611
DR   Cosmic; 930046
DR   Wikidata; Q54812512
RX   PubMed=11212268;
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/CHLA-95_Cell_Line_Data_Sheet_COGcell_org.pdf
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 9,14
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 17,23
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 12,13
ST   FGA: 20,23
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
RX   PubMed=11212268;
RA   Thompson, Patricia M.
RA   Maris, John Matthew
RA   Hogarty, Michael D.
RA   Seeger, Robert C.
RA   Reynolds, Charles Patrick
RA   Brodeur, Garrett M.
RA   White, Peter S.
RT   "Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36
RT   or at other tumor suppressor loci in neuroblastoma.";
RL   Cancer Res. 61:679-686(2001).
//